A Phase 3 Clinical Trial of ^<123>I-Iomazenil, a New Central-Type Benzodiazepine Receptor Imaging Agent (Part 3) : Report on Clinical Usefulness in Epilepsy

• TORIZUKA Kanji

  Fukui Medical School

• UEMURA Kazuo

  Akita Research Institute for Brain and Blood Vessels

• TORU Michio

  Department of Psychiatry, Tokyo Medical and Dental University

• SHINOHARA Yukito

  Department of Neurology, Tokai University

• NISHIMURA Tsunehiko

  Department of Tracer Kinetics, Osaka University

• YONEKURA Yoshiharu

  Department of Brain Pathophysiology, Kyoto University

• NAKAGAWARA Jyoji

  Department of Neurosurgery, Nakamura Memorial Hospital

• MATSUDA Hiroshi

  Department of Radiology, National Center Hospital for Mental, Nervous, and Muscular Disorders, NCNP

• SAKAI Fumihiko

  Department of Internal Medicine, Kitasato University

• MATSUDA Kazumi

  Department of Neurosurgery, National Epilepsy Center, Shizuoka-Higashi Hospital

• FUKUYAMA Hidenao

  Department of Neurology (currently Department of Brain Pathophysiology), Kyoto University

• MORIMOTO Kiyoshi

  Department of Neuropsychiatry, Kagawa Medical School

Bibliographic Information

Other Title

• 中枢性ベンゾジアゼピン受容体イメージング剤^<123>I-イオマゼニルの第3相臨床試験(第3報) : てんかんにおける臨床的有用性の検討

Journal

• 核医学

  核医学 33 (3), 319-328, 1996-03-20

Keywords

• ^<123>I-Iomazenil
• Benzodiazepine recepter
• Epilepsy
• Phase 3 study

Details

• CRID: 1570854174703775360
• NII Article ID: 10008535912
• NII Book ID: AN00038394
• ISSN: 00227854
• Web Site: https://search.jamas.or.jp/link/ui/1996202989
• Text Lang: ja
• Data Source:
  • CiNii Articles